4//SEC Filing
Winningham Rick E 4
Accession 0001415889-24-027297
CIK 0001583107other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 9:08 PM ET
Size
6.6 KB
Accession
0001415889-24-027297
Insider Transaction Report
Form 4
Winningham Rick E
DirectorChief Executive Officer
Transactions
- Award
Ordinary Shares
2024-11-14$9.57/sh+3,193$30,557→ 1,827,092 total
Holdings
- 3,900(indirect: As Custodian)
Ordinary Shares
- 92,567(indirect: By Trust)
Ordinary Shares
Footnotes (1)
- [F1]This transaction is being reported late due to inadvertent administrative error. Reflects an acquisition from the Issuer pursuant to a restricted share purchase agreement under the Issuer's Amended and Restated 2013 Equity Incentive Plan at a per-share price equal to the closing per-share price of the Issuer's ordinary shares on the Nasdaq Global Market on November 14, 2024. Transaction was with the Issuer and did not involve an open market transaction.
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0001302443
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 9:08 PM ET
- Size
- 6.6 KB